These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32839881)

  • 1. An Investigation into the Influence of Process Parameters and Formulation Variables on Compaction Properties of Liquisolid Systems.
    Aleksić I; German Ilić I; Cvijić S; Parojčić J
    AAPS PharmSciTech; 2020 Aug; 21(7):242. PubMed ID: 32839881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
    Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
    Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EVALUATION OF SORPTIVE PROPERTIES OF VARIOUS CARRIERS AND COATING MATERIALS FOR LIQUISOLID SYSTEMS.
    Vraníková B; Gajdziok J
    Acta Pol Pharm; 2015; 72(3):539-49. PubMed ID: 26642662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
    Kulkarni AS; Gaja JB
    PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers.
    Glišić T; Djuriš J; Vasiljević I; Parojčić J; Aleksić I
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of compressibility and compactibility parameters of roller compacted Theophylline and its binary mixtures.
    Hadžović E; Betz G; Hadžidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2011 Sep; 416(1):97-103. PubMed ID: 21704142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPTIMIZATION OF FUROSEMIDE LIQUISOLID TABLETS PREPARATION PROCESS LEADING TO THEIR MASS AND SIZE REDUCTION.
    Kurek M; Woyna-Orlewicz K; Khalid MH; Jachowicz R
    Acta Pol Pharm; 2016 Sep; 73(5):1325-1331. PubMed ID: 29638072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation into liquisolid system processability based on the SeDeM Expert System approach.
    Vasiljević I; Turković E; Nenadović S; Mirković M; Zimmer A; Parojčić J; Aleksić I
    Int J Pharm; 2021 Aug; 605():120847. PubMed ID: 34216763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA; Kamel AO; Sammour OA
    Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data-driven insights into the properties of liquisolid systems based on machine learning algorithms.
    Vasiljević I; Turković E; Parojčić J
    Eur J Pharm Sci; 2024 Dec; 203():106927. PubMed ID: 39378961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.